$ENSG Cashflow Statement | Understand Stock

$ENSG

$169.50 -$7.42 (4.19%) Close

$ENSG Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income
Net income from discontinued operations, net of tax
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Amortization of deferred financing fees
Non-cash leasing arrangement
Impairment of long-lived assets
Write-off of deferred financing fees
Deferred income taxes
Provision for doubtful accounts
Stock-based compensation
Cash received from insurance proceeds
Loss (gain) on sale of assets
(Gain)/loss on insurance claims, legal matters and asset disposals
Loss (gain) on insurance claims and asset disposals
Litigation
Insurance proceeds and (gain) loss on long-lived assets, net
Other operating activities, net
Change in operating assets and liabilities
Accounts receivable
Prepaid income taxes
Prepaid expenses and other assets
Deferred employer portion of social security taxes
Cash surrender value of life insurance policy premiums
Deferred compensation liability
Operating lease obligations
Accounts payable
Accrued wages and related liabilities
Other accrued liabilities
Accrued self-insurance liabilities
Other long-term liabilities
Net cash provided by discontinued operating activities (Note 22)
NET CASH PROVIDED BY OPERATING ACTIVITIES

Cash flows from investing activities:
Purchase of property and equipment
Cash payments for business acquisitions (Note 7)
Cash payments for asset acquisitions (Note 7)
Escrow deposits
Escrow deposits used to fund acquisitions
Cash payments for acquisitions
Cash from insurance proceeds
Cash proceeds from the sale of assets
Deconsolidation of an ancillary business
Cash payments for Medicare and Medicaid licenses
Cash proceeds from insurance recoveries and sale of assets
Purchases of investments
Maturities of investments
Other investing activities, net
Net cash used in discontinued investing activities (Note 22)
NET CASH USED IN INVESTING ACTIVITIES

Cash flows from financing activities:
Proceeds from debt (Note 13)
Payments on debt
Issuance of common stock upon exercise of options
Repurchase of shares of common stock to satisfy tax withholding obligations
Repurchase of shares of common stock (Note 19)
Dividends paid
Dividends received from Pennant
Cash retained by Pennant at spin-off
Proceeds from sale of subsidiary shares
Non-controlling interest distribution
Contribution from noncontrolling interest
Purchase of non-controlling interest
Payment of contingent consideration
Payments of deferred financing costs
Proceeds from CARES Act Provider Relief Fund and Medicare Advance Payment Program (Note 3)
Repayments of CARES Act Provider Relief Fund and Medicare Advance Payment Program (Note 3)
Net cash (used in)/provided by financing activities
Net cash used in discontinued financing activities
Other financing activities
NET CASH USED IN FINANCING ACTIVITIES

Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents beginning of period
Cash and cash equivalents end of period
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Cash paid during the period for:
Interest
Income taxes
Lease liabilities
Non-cash financing and investing activity
Accrued capital expenditures
Accrued dividends declared
Note receivable from insurance settlement
Right-of-use assets obtained in exchange for new and modified operating lease obligations
Distribution of net assets to Pennant

Comments